VTGN•benzinga•
Vistagen To Proceed With PALISADE-2 Phase 3 Clinical Trial Of PH94B In Social Anxiety Disorder following Interim Analysis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 8, 2022 by benzinga